Combination intraperitoneal Carboplatin and intravenous and intraperitoneal Paclitaxel in the management of advanced-stage ovarian cancer.

INTRODUCTION:Intraperitoneal (IP) chemotherapy is known to be effective after optimal primary debulking surgery for ovarian cancer. We conducted a pilot study to investigate a regimen of combination IP carboplatin and intravenous (IV) and IP paclitaxel.METHODS:A prospectively maintained database was